Viewing StudyNCT00343187

Bugs

eRecord

Ignite Creation Date: 2024-05-05 @ 4:54 PM

Last Modification Date: 2024-10-26 @ 9:25 AM

Study NCT ID: NCT00343187

Status: TERMINATED

Last Update Posted: 2011-05-30

First Post: 2006-06-20

Brief Title: A Phase II Study of ACZONE Dapsone Gel 5 As a Treatment For Tarceva ErlotinibRelated Rash

Sponsor: Allergan

Organization: Allergan

Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions:

Keywords:

Name	View

Tarceva	View
Rash	View
EGFR-1 Rash	View
erlotinib	View
Aczone	View
Dapsone	View
Non-small Cell Lung Cancer	View
subjects treated with Tarceva for non-small cell lung cancer NSCLC who subsequently develop a rash suspected to be related to Tarceva	View